Publications (89) ENCARNACIÓN GONZÁLEZ RODRÍGUEZ publications

filter_list

2026

  1. Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 44, Núm. 9, pp. 774-786

  2. Correction: SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025)(Clinical and Translational Oncology, 10.1007/s12094-025-04140-4)

    Clinical and Translational Oncology

  3. Corrigendum to “Is cancer increasing in young adults in Spain? Incidence trends from the Spanish Network of Cancer Registries (REDECAN)”(European Journal of Cancer, (2026), 244, C, (116883), (S0959804926006647), 10.1016/j.ejca.2026.116883)

    European Journal of Cancer

  4. Diagnostic Performance and Misclassification Patterns of Preoperative MRI in Rectal Cancer: A Real-World Study

    Diagnostics, Vol. 16, Núm. 10

  5. Intratumoral Fusobacterium species and survival in resectable colorectal cancer: a multicenter cohort study

    ESMO Open, Vol. 11, Núm. 8

  6. Is cancer increasing in young adults in Spain? Incidence trends from the Spanish Network of Cancer Registries (REDECAN)

    European Journal of Cancer, Vol. 244

  7. MRI-based assessment and surveillance in watch-and-wait for rectal cancer: a multidisciplinary review

    European Journal of Radiology, Vol. 203

  8. Proximal-To-Distal Gradient and Its Implications in Differentiation and Prognosis in Colorectal Neuroendocrine Neoplasms: The RGETNE-HERACLES Study

    Acta Haematologica, pp. 1-16

  9. Real-world effectiveness and safety of Sacituzumab Govitecan in metastatic triple-negative breast cancer: results from the multicenter retrospective observational SACISUR cohort in Southern Spain

    Frontiers in Oncology, Vol. 16

  10. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2025)

    Clinical and Translational Oncology, Vol. 28, Núm. 2, pp. 451-462

  11. Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Genes and Their Contribution to Breast Cancer Therapy

    Pharmaceutics, Vol. 18, Núm. 6

  12. Tumour Jagged1 expression as a prognostic marker of bevacizumab response and modulation of 5-fluorouracil efficacy through γ-secretase inhibition in colorectal cancer

    Gastroenterology Report, Vol. 14

  13. What cancers are increasing in young adults: a population-based study of incidence trends in adults 20–49 years old in the South of Spain

    BMC Public Health, Vol. 26, Núm. 1

2025

  1. Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients

    Clinical and Translational Oncology, Vol. 27, Núm. 3, pp. 909-934

  2. Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention

    Cancers, Vol. 17, Núm. 4

  3. Evaluation of PTSO delivery approaches for gut microbiota modulation in colorectal cancer: A comparative study of microcapsules containing Allium derivatives

    Journal of Functional Foods, Vol. 128

  4. Gender and sex differences in colorectal cancer screening, diagnosis and treatment

    Clinical and Translational Oncology, Vol. 27, Núm. 7, pp. 2825-2837

  5. Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study

    Clinical and Translational Oncology, Vol. 27, Núm. 3, pp. 1176-1184

  6. Risk of a second primary cancer after breast cancer in Southern Spain: a population-based study over 3 decades

    Maturitas, Vol. 199

  7. Socioeconomic inequalities in adherence to clinical practice guidelines and breast cancer survival: a multicentre population-based study in Spain

    BMJ Quality and Safety, Vol. 34, Núm. 12, pp. 810-823